XML 74 R62.htm IDEA: XBRL DOCUMENT v3.21.1

Commitments and Contingencies (Details)								1 Months Ended	3 Months Ended	6 Months Ended	12 Months Ended	16 Months Ended	18 Months Ended
	Sep. 11, 2020	Oct. 02, 2019	Sep. 11, 2019 patent	Nov. 30, 2018 patent	Feb. 22, 2018 patent	Mar. 24, 2015 patent	Feb. 11, 2015 patent	Oct. 31, 2019 case	Mar. 31, 2021 lawsuit patent case state	Jun. 30, 2020 patent	Dec. 31, 2018 patent	Sep. 30, 2017 patent	Apr. 30, 2017 patent lawsuit
Commitments and Contingencies
Period that gives the Company a 30-month stay of FDA approval while the parties have an opportunity to litigate					45 days
Additional patent listed										4
Xtampza ER
Commitments and Contingencies
Number of total patent									19
Xtampza ER Litigation
Commitments and Contingencies
Number of patents listed in FDA Orange Book							11
Stay period before FDA can issue a final approval unless it is terminated							30 months
Number of patents allegedly infringed							5					2	2
Number of lawsuits filed | lawsuit													2
PTAB duration for issuing decision		1 year
Statutory period of proceedings	18 months
Xtampza ER Litigation | Maximum
Commitments and Contingencies
PTAB extended duration for issuing decision		6 months
Xtampza ER Litigation, District of Delaware
Commitments and Contingencies
Stay period before FDA can issue a final approval unless it is terminated						30 months
Number of patents allegedly infringed						3
Xtampza ER Litigation, District of Massachusetts
Commitments and Contingencies
Stay period before FDA can issue a final approval unless it is terminated						30 months
Number of patents found not infringed						3
Teva Litigation
Commitments and Contingencies
Number of patents listed in FDA Orange Book					12				19
Number of Orange Book patents asserted to have been infringed				2
Stay period before FDA can issue a final approval unless it is terminated					30 months
Number of patents found not infringed					11
Number of terms or sets of terms addressed			2
Number of terms or sets of terms in dispute			6
Additional patent listed											2
Opioid Litigation
Commitments and Contingencies
Number of lawsuits filed | lawsuit									6
Number of lawsuits designated as representative cases | lawsuit									0
Number of lawsuits designated as Track One case | lawsuit									0
Multi-District Litigation (MDL)
Commitments and Contingencies
Number of states filed cases | state									3
Total number of cases brought primarily by states, cities, counties, and other local entities | case									2,000
Number of lawsuits filed								2	21
Number of lawsuits currently stayed | case									8
Number of lawsuits settled | lawsuit									13
Number of lawsuits dismissed | lawsuit									3

X

- Definition

Initial duration for issuing its decision by PTAB.

+ References

No definition available.

+ Details

Name:	coll_DurationForDecisionIssue
Namespace Prefix:	coll_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Extended period for issuing its decision by PTAB.

+ References

No definition available.

+ Details

Name:	coll_ExtendedDurationForDecisionIssue
Namespace Prefix:	coll_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Number of another entity's Orange Book patents that the entity has allegedly infringed.

+ References

No definition available.

+ Details

Name:	coll_LossContingencyOrangeBookPatentsAllegedlyInfringedNumber
Namespace Prefix:	coll_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Represents the stay period before the Federal Drug Administration (FDA) can issue final approval unless the stay is terminated.

+ References

No definition available.

+ Details

Name:	coll_LossContingencyStayPeriodBeforeFinalFederalDrugAdministrationApprovalCanBeIssuedIfPatentInfringementLitigationElected
Namespace Prefix:	coll_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Number of additional patents listed during the period.

+ References

No definition available.

+ Details

Name:	coll_NumberOfAdditionalPatentsListed
Namespace Prefix:	coll_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

X

- Definition

This represents information pertaining to number of lawsuits currently stayed.

+ References

No definition available.

+ Details

Name:	coll_NumberOfLawsuitsCurrentlyStayed
Namespace Prefix:	coll_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

X

- Definition

Number of lawsuits designated as representative cases.

+ References

No definition available.

+ Details

Name:	coll_NumberOfLawsuitsDesignatedAsRepresentativeCases
Namespace Prefix:	coll_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

X

- Definition

Number of lawsuits designated as Track One case.

+ References

No definition available.

+ Details

Name:	coll_NumberOfLawsuitsDesignatedTrackOneCase
Namespace Prefix:	coll_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

X

- Definition

Total number of cases brought primarily by states, cities, counties, and other local entities.

+ References

No definition available.

+ Details

Name:	coll_NumberOfLawsuitsFiled
Namespace Prefix:	coll_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Number of patents listed in FDA Orange Book

+ References

No definition available.

+ Details

Name:	coll_NumberOfPatentsListedInFdaOrangeBook
Namespace Prefix:	coll_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Number of states filed cases.

+ References

No definition available.

+ Details

Name:	coll_NumberOfStatesFiledCases
Namespace Prefix:	coll_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Number of terms or sets of terms, that are in dispute, are addressed in a Report and Recommendation.

+ References

No definition available.

+ Details

Name:	coll_NumberOfTermsOrSetsOfTermsAddressed
Namespace Prefix:	coll_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Number of terms or sets of terms that are in dispute.

+ References

No definition available.

+ Details

Name:	coll_NumberOfTermsOrSetsOfTermsInDispute
Namespace Prefix:	coll_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Number of total patents listed during the period.

+ References

No definition available.

+ Details

Name:	coll_NumberOfTotalPatentsListed
Namespace Prefix:	coll_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Period that gives the Company a 30-month stay of FDA approval while the parties have an opportunity to litigate.

+ References

No definition available.

+ Details

Name:	coll_PeriodStayOfApprovalAndOpportunityToLitigate
Namespace Prefix:	coll_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Statutory period of proceedings.

+ References

No definition available.

+ Details

Name:	coll_StatutoryPeriodOfProceedings
Namespace Prefix:	coll_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_LossContingenciesLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Number of claims dismissed.

+ References

No definition available.

+ Details

Name:	us-gaap_LossContingencyClaimsDismissedNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The number of claims settled and dismissed during the period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349

+ Details

Name:	us-gaap_LossContingencyClaimsSettledAndDismissedNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The total number of new claims filed pertaining to a loss contingency during the period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349

+ Details

Name:	us-gaap_LossContingencyNewClaimsFiledNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Number of another entity's patents that the entity has allegedly infringed.

+ References

No definition available.

+ Details

Name:	us-gaap_LossContingencyPatentsAllegedlyInfringedNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Number of another entity's patents that the entity was found not to have infringed.

+ References

No definition available.

+ Details

Name:	us-gaap_LossContingencyPatentsFoundNotInfringedNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	srt_ProductOrServiceAxis=coll_XtampzaMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_LitigationCaseAxis=coll_PurduePharmaLimitedPartnershipPatentInfringementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_LitigationCaseAxis=coll_PurduePharmaLimitedPartnershipPatentInfringementDistrictOfDelawareMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_LitigationCaseAxis=coll_PurduePharmaLimitedPartnershipPatentInfringementDistrictOfMassachusettsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_LitigationCaseAxis=coll_TevaLitigationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_LitigationCaseAxis=coll_OpioidLitigationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_LitigationCaseAxis=coll_MultiDistrictLitigationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: